This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

April 22 Premarket Briefing: 10 Things You Should Know

Stocks in this article: NFLX CMCSA T MCD AGN NVS VRX F

Updated from 6:46 a.m. EDT

Here are 10 things you should know for Tuesday, April 22:

1.
-- U.S. stock futures were pointing to a weaker start on Tuesday ahead of earnings from a number of sector heavyweights and home-sales data.

European stocks rose. Asian shares ended the session mixed; Japan's Nikkei 225 fell 0.9%.

2.-- The economic calendar in the U.S. on Tuesday includes existing-home sales for March at 10 a.m. EDT.

3.-- U.S. stocks on Monday closed higher as investors awaited critical earnings reports this week.

The Dow Jones Industrial Average added 0.25% to finish at 16,449.25, the S&P 500 gained 0.38% to 1,871.89 and the Nasdaq climbed 0.64% to close at 4,121.55. The gains marked the S&P's fifth straight positive session.

4. -- Valeant Pharmaceuticals (VRX) is teaming up with activist investor Bill Ackman in a bid for Allergan (AGN), the Botox maker, that could be worth about $40 billion.

The offer was confirmed Tuesday by Valeant.

Ackman's Pershing Square Capital Management said it owns a 9.7% stake in Allergan worth $4.1 billion. Ackman's stake would make an Allergan deal worth around $40 billion.

Valeant shares rose 11.3% in premarket trading to $140.30. Allergan rose 21.9% to $173.15.

5. -- Switzerland's Novartis (NVS) agreed to buy GlaxoSmithKline's (GSK) cancer-drug business for $14.5 billion, plus up to $1.5 billion more if certain milestones are met, and to divest most of its vaccines business to Glaxo for $7.1 billion, plus royalties.

The two drugmakers also are creating a new consumer health care business through a joint venture. 

Novartis also said it would sell off its animal health division to Eli Lilly (LLY) for about $5.4 billion.

Novartis shares were up 1% in premarket trading to $86.34; GlaxoSmithKline shares rose 4.4% to $55.48; Lilly shares fell 3.1% to $59. 

6. -- Netflix (NFLX), the online entertainment company, posted mixed first-quarter results on Monday and said it topped 35 million streaming subscribers. The company also announced a price increase for new members.

Netflix earned 86 cents a share on revenue of $1.27 billion in the first quarter; analysts were expecting earnings of 83 cents a share on revenue of $1.27 billion.

Netflix said streaming margins hit 25.2% in the first quarter. 

CEO Reed Hastings said there would be an increase for new members of $1 or $2, depending on the country.

Netflix shares rose 6.9% in premarket trading to $372.50.

7. -- Ford (F) will soon name Mark Fields its next CEO and reveal when current CEO Alan Mulally will retire from the company he is credited with saving, Bloomberg reported, citing two people familiar with the pending announcement.

Mulally, 68, will step down before the end of the year and be succeeded by Fields, 53, now chief operating officer, according to the people. The automaker may announce the moves as soon as May 1, the people told Bloomberg.

Ford fell 0.1%.

8. -- Comcast (CMCSA) posted first-quarter adjusted earnings of 68 cents a share, ahead of forecasts of 64 cents. Revenue rose 14% to $17.41 billion.

The stock rose 0.7% to $50.22 in premarket trading.

9. -- AT&T (T) is expected by analysts to post earnings of 70 cents a share in the first quarter on revenue of $32.44 billion.

10. -- McDonald's (MCD) posedt first-quarter profit of $1.21 share, below estimates of $1.24 a share.

-- Written by Joseph Woelfel

To contact the writer of this article, click here:Joseph Woelfel

To submit a news tip, send an email to:tips@thestreet.com.

Follow @josephwoe58

 

Copyright 2014 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs